CytomX Therapeutics (CTMX) Return on Capital Employed Growth (3y) (2018 - 2026)
CytomX Therapeutics (CTMX) Return on Capital Employed Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-494.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
CytomX Therapeutics |
520.30 Mn |
173.59 Mn |
- |
5,692.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
5,692.00 |
| Dec 31, 2025 |
10,793.00 |
| Sep 30, 2025 |
12,442.00 |
| Jun 30, 2025 |
11,387.00 |
| Mar 31, 2025 |
11,467.00 |
| Dec 31, 2024 |
9,865.00 |
| Sep 30, 2024 |
5,541.00 |
| Jun 30, 2024 |
4,743.00 |
| Mar 31, 2024 |
5,193.00 |
| Dec 31, 2023 |
1,528.00 |
| Sep 30, 2023 |
2,089.00 |
| Jun 30, 2023 |
-2,093.00 |
| Mar 31, 2023 |
-3,156.00 |
| Dec 31, 2022 |
-5,911.00 |
| Sep 30, 2022 |
-7,416.00 |
| Jun 30, 2022 |
-4,171.00 |
| Mar 31, 2022 |
-3,182.00 |
| Dec 31, 2021 |
-2,089.00 |
| Sep 30, 2021 |
-1,743.00 |
| Jun 30, 2021 |
-1,374.00 |
